Sign in

Publications

Search in 13050 publications:

Reset RSS
Time frame
13050 Publication(s)
Jan 13, 2021
External Validation of the Timed Up and Go Test as Measure of Objective Functional Impairment in Patients With Lumbar Degenerative Disc Disease
Ziga M. External Validation of the Timed Up and Go Test as Measure of Objective Functional Impairment in Patients With Lumbar Degenerative Disc Disease. Neurosurgery 2021
Jan 13, 2021
External Validation of the Timed Up and Go Test as Measure of Objective Functional Impairment in Patients With Lumbar Degenerative Disc Disease
Jan 13, 2021

Neurosurgery 2021

Ziga Michal

more
Jan 13, 2021
External Validation of the Timed Up and Go Test as Measure of Objective Functional Impairment in Patients With Lumbar Degenerative Disc Disease
Zeitlberger A. External Validation of the Timed Up and Go Test as Measure of Objective Functional Impairment in Patients With Lumbar Degenerative Disc Disease. Neurosurgery 2021
Jan 13, 2021
External Validation of the Timed Up and Go Test as Measure of Objective Functional Impairment in Patients With Lumbar Degenerative Disc Disease
Jan 13, 2021

Neurosurgery 2021

Zeitlberger Anna

more
Jan 13, 2021
Development of a Complication- and Treatment-Aware Prediction Model for Favorable Functional Outcome in Aneurysmal Subarachnoid Hemorrhage Based on Machine Learning
Zeitlberger A. Development of a Complication- and Treatment-Aware Prediction Model for Favorable Functional Outcome in Aneurysmal Subarachnoid Hemorrhage Based on Machine Learning. Neurosurgery 2021
Jan 13, 2021
Development of a Complication- and Treatment-Aware Prediction Model for Favorable Functional Outcome in Aneurysmal Subarachnoid Hemorrhage Based on Machine Learning
Jan 13, 2021

Neurosurgery 2021

Zeitlberger Anna

more
Jan 13, 2021
External Validation of the Timed Up and Go Test as Measure of Objective Functional Impairment in Patients With Lumbar Degenerative Disc Disease
Stienen M, Maldaner N, Sosnova M, Zeitlberger A, Ziga M, Weyerbrock A, Bozinov O, Gautschi O. External Validation of the Timed Up and Go Test as Measure of Objective Functional Impairment in Patients With Lumbar Degenerative Disc Disease. Neurosurgery 2021; 88:E142-E149.
Jan 13, 2021
External Validation of the Timed Up and Go Test as Measure of Objective Functional Impairment in Patients With Lumbar Degenerative Disc Disease
Jan 13, 2021

Neurosurgery 2021; 88:E142-E149

Stienen Martin N., Maldaner Nicolai, Sosnova Marketa, Zeitlberger Anna M, Ziga Michal, Weyerbrock Astrid, Bozinov Oliver, Gautschi Oliver P

more
Jan 13, 2021
Development of a Complication- and Treatment-Aware Prediction Model for Favorable Functional Outcome in Aneurysmal Subarachnoid Hemorrhage Based on Machine Learning
Maldaner N, Burkhardt J, Chiappini A, Robert T, Schatlo B, Schmid J, Maduri R, Staartjes V, Seule M, Weyerbrock A, Serra C, Stienen M, Bozinov O, Daniel R, Fandino J, Marbacher S, Zeitlberger A, Sosnova M, Goldberg J, Fung C, Bervini D, May A, Bijlenga P, Schaller K, Roethlisberger M, Rychen J, Zumofen D, D'Alonzo D, Regli L. Development of a Complication- and Treatment-Aware Prediction Model for Favorable Functional Outcome in Aneurysmal Subarachnoid Hemorrhage Based on Machine Learning. Neurosurgery 2021; 88:E150-E157.
Jan 13, 2021
Development of a Complication- and Treatment-Aware Prediction Model for Favorable Functional Outcome in Aneurysmal Subarachnoid Hemorrhage Based on Machine Learning
Jan 13, 2021

Neurosurgery 2021; 88:E150-E157

Maldaner Nicolai, Burkhardt Jan-Karl, Chiappini Alessio, Robert Thomas, Schatlo Bawarjan, Schmid Josef, Maduri Rodolfo, Staartjes Victor E, Seule Martin A, Weyerbrock Astrid, Serra Carlo, Stienen Martin N., Bozinov Oliver, Daniel Roy Thomas, Fandino Javier, Marbacher Serge, Zeitlberger Anna M, Sosnova Marketa, Goldberg Johannes, Fung Christian, Bervini David, May Adrien, Bijlenga Philippe, Schaller Karl, Roethlisberger Michel, Rychen Jonathan, Zumofen Daniel W, D'Alonzo Donato, Regli Luca

more
Jan 11, 2021
Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019.
Sutter R, Hert L, De Marchis G, Twerenbold R, Kappos L, Naegelin Y, Kuster G, Benkert P, Jost J, Maceski A, Rüegg S, Siegemund M, Leppert D, Tschudin-Sutter S, Kuhle J. Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019. Ann Neurol 2021; 89:610-616.
Jan 11, 2021
Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019.
Jan 11, 2021

Ann Neurol 2021; 89:610-616

Sutter Raoul, Hert Lisa, De Marchis Gian Marco, Twerenbold Raphael, Kappos Ludwig, Naegelin Yvonne, Kuster Gabriela M, Benkert Pascal, Jost Jasmine, Maceski Aleksandra Maleska, Rüegg Stephan, Siegemund Martin, Leppert David, Tschudin-Sutter Sarah, Kuhle Jens

more
Jan 11, 2021
Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial
Rassouli F, Tamm M, Sievi N, Tschirren U, Widmer S, Kähler C, Brack T, Thurnheer R, Stolz D, Kohler M, Baty F, Germann A, Brutsche M. Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial. J Intern Med 2021; 289:404-410.
Jan 11, 2021
Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial
Jan 11, 2021

J Intern Med 2021; 289:404-410

Rassouli Frank, Tamm M, Sievi N A, Tschirren U, Widmer Sandra, Kähler C, Brack T, Thurnheer R, Stolz D, Kohler M, Baty Florent, Germann A, Brutsche Martin

more
Jan 7, 2021
Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group
Ostheimer C, Dobiasch S, Arnold C, Oertel M, Haussmann J, Gauer T, Goy Y, Suess C, Ziegler S, Panje C, Baues C, Trommer M, Skripcak T, Billiet C, Thieme A, Kaul D, Mäurer M, Ebert N, Schmitt D, Krug D, Baumann R, Henkenberens C, Giordano F, Sautter L, López G, Fleischmann D, Niyazi M, Käsmann L, Medenwald D. Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group. Strahlenther Onkol 2021; 197:385-395.
Jan 7, 2021
Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group
Jan 7, 2021

Strahlenther Onkol 2021; 197:385-395

Ostheimer C, Dobiasch S, Arnold C R, Oertel M, Haussmann J, Gauer T, Goy Y, Suess C, Ziegler S, Panje Cédric, Baues C, Trommer M, Skripcak T, Billiet C, Thieme A H, Kaul D, Mäurer M, Ebert N, Schmitt D, Krug D, Baumann R, Henkenberens C, Giordano F A, Sautter L, López Guerra, Fleischmann D F, Niyazi M, Käsmann L, Medenwald D

more
Jan 7, 2021
The Lisbon Agreement on femoroacetabular impingement imaging-part 2: general issues, parameters, and reporting
Mascarenhas V, Robinson P, Karantanas A, Sudoł-Szopińska I, Anderson S, Noebauer-Huhmann I, Marin-Peña O, Collado D, Tey-Pons M, Schmaranzer E, Padron M, Kramer J, Zingg P, De Maeseneer M, Jans L, Dietrich T, Vanhoenacker F, Castro M, Afonso P, Rego P, Dienst M, Sutter R, Schmaranzer F, Sconfienza L, Kassarjian A, Ayeni O, Beaulé P, Dantas P, Lalam R, Weber M, Llopis E. The Lisbon Agreement on femoroacetabular impingement imaging-part 2: general issues, parameters, and reporting. Eur Radiol 2021
Jan 7, 2021
The Lisbon Agreement on femoroacetabular impingement imaging-part 2: general issues, parameters, and reporting
Jan 7, 2021

Eur Radiol 2021

Mascarenhas Vasco V, Robinson Philip, Karantanas Apostolos H, Sudoł-Szopińska Iwona, Anderson Suzanne, Noebauer-Huhmann Iris, Marin-Peña Oliver, Collado Diego, Tey-Pons Marc, Schmaranzer Ehrenfried, Padron Mario, Kramer Josef, Zingg Patrick O, De Maeseneer Michel, Jans Lennart, Dietrich Tobias, Vanhoenacker Filip M, Castro Miguel O, Afonso P Diana, Rego Paulo, Dienst Michael, Sutter Reto, Schmaranzer Florian, Sconfienza Luca, Kassarjian Ara, Ayeni Olufemi R, Beaulé Paul E, Dantas Pedro, Lalam Radhesh, Weber Marc-André, Llopis Eva

more
Jan 7, 2021
The Lisbon Agreement on Femoroacetabular Impingement Imaging-part 3: imaging techniques
Castro M, Robinson P, Karantanas A, Sudoł-Szopińska I, Anderson S, Noebauer-Huhmann I, Marin-Peña O, Collado D, Tey-Pons M, Schmaranzer E, Padron M, Kramer J, Zingg P, De Maeseneer M, Jans L, Dietrich T, Vanhoenacker F, Mascarenhas V, Afonso P, Rego P, Schmaranzer F, Sutter R, Kassarjian A, Sconfienza L, Dienst M, Ayeni O, Beaulé P, Dantas P, Lalam R, Weber M, Llopis E. The Lisbon Agreement on Femoroacetabular Impingement Imaging-part 3: imaging techniques. Eur Radiol 2021
Jan 7, 2021
The Lisbon Agreement on Femoroacetabular Impingement Imaging-part 3: imaging techniques
Jan 7, 2021

Eur Radiol 2021

Castro Miguel O, Robinson Philip, Karantanas Apostolos H, Sudoł-Szopińska Iwona, Anderson Suzanne, Noebauer-Huhmann Iris, Marin-Peña Oliver, Collado Diego, Tey-Pons Marc, Schmaranzer Ehrenfried, Padron Mario, Kramer Josef, Zingg Patrick O, De Maeseneer Michel, Jans Lennart, Dietrich Tobias, Vanhoenacker Filip M, Mascarenhas Vasco V, Afonso P Diana, Rego Paulo, Schmaranzer Florian, Sutter Reto, Kassarjian Ara, Sconfienza Luca, Dienst Michael, Ayeni Olufemi R, Beaulé Paul E, Dantas Pedro, Lalam Radhesh, Weber Marc-André, Llopis Eva

more
Jan 7, 2021
Neue Therapien und aggressivere Regime beim Ovarialkarzinom – ein Benefit für die Patientin? (Vorsitzender)
Markus A (2021). Neue Therapien und aggressivere Regime beim Ovarialkarzinom – ein Benefit für die Patientin? (Vorsitzender). Presented at: Neujahrsfortbildung Frauenklinik 2021, St. Gallen
Jan 7, 2021
Neue Therapien und aggressivere Regime beim Ovarialkarzinom – ein Benefit für die Patientin? (Vorsitzender)
Jan 7, 2021

Neujahrsfortbildung Frauenklinik 2021

Markus Alexander

more
Jan 7, 2021
Neue Therapien und aggressivere Regime beim Ovarialkarzinom - ein Benefit für die Patientin? Fallstudie Hypertherme Intraperitoneale Chemotherapie (HIPEC)
Bolla N (2021). Neue Therapien und aggressivere Regime beim Ovarialkarzinom - ein Benefit für die Patientin? Fallstudie Hypertherme Intraperitoneale Chemotherapie (HIPEC). Presented at: Neujahrsfortbildung Frauenklinik 2021, St. Gallen
Jan 7, 2021
Neue Therapien und aggressivere Regime beim Ovarialkarzinom - ein Benefit für die Patientin? Fallstudie Hypertherme Intraperitoneale Chemotherapie (HIPEC)
Jan 7, 2021

Neujahrsfortbildung Frauenklinik 2021

Bolla Nicole

more
Jan 7, 2021
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy
Furlanetto J, Lederer B, Gerber B, Zahm D, Bauerfeind I, Nekljudova V, Hanusch C, Jackisch C, Link T, Hahnen E, Loibl S, Couch F, Schmutzler R, Möbus V, Schneeweiss A, Rhiem K, Tesch H, Blohmer J, Lübbe K, Untch M, Salat C, Huober J, Klare P, Fasching P. Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy. Eur J Cancer 2021; 145:44-52.
Jan 7, 2021
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy
Jan 7, 2021

Eur J Cancer 2021; 145:44-52

Furlanetto Jenny, Lederer Bianca, Gerber Bernd, Zahm Dirk-Michael, Bauerfeind Ingo, Nekljudova Valentina, Hanusch Claus, Jackisch Christian, Link Theresa, Hahnen Eric, Loibl Sibylle, Couch Fergus J, Schmutzler Rita, Möbus Volker, Schneeweiss Andreas, Rhiem Kerstin, Tesch Hans, Blohmer Jens-Uwe, Lübbe Kristina, Untch Michael, Salat Christoph, Huober Jens, Klare Peter, Fasching Peter A

more
Jan 7, 2021
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. Reply
Rubbert-Roth A, Xavier R. Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. Reply. N Engl J Med 2021; 384:83-84.
Jan 7, 2021
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. Reply
Jan 7, 2021

N Engl J Med 2021; 384:83-84

Rubbert-Roth Andrea, Xavier Ricardo M

more
Jan 6, 2021
Pre-transplant Social Adaptability Index and clinical outcomes in renal transplantation - The Swiss Transplant Cohort Study
Denhaerynck K, Goldfarb-Rumyantzev A, Sandhu G, Beckmann S, Huynh-Do U, Binet F, De Geest S, Psychosocial Interest Group, Swiss Transplant Cohort Study. Pre-transplant Social Adaptability Index and clinical outcomes in renal transplantation - The Swiss Transplant Cohort Study. Clin Transplant 2021:e14218.
Jan 6, 2021
Pre-transplant Social Adaptability Index and clinical outcomes in renal transplantation - The Swiss Transplant Cohort Study
Jan 6, 2021

Clin Transplant 2021:e14218

Denhaerynck Kris, Goldfarb-Rumyantzev Alexander S, Sandhu Gurprataap, Beckmann Sonja, Huynh-Do Uyen, Binet Françoise-Isabelle, De Geest Sabina, Psychosocial Interest Group, Swiss Transplant Cohort Study

more
Jan 6, 2021
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database
Kroeze S, Eckert F, Lohaus F, Sackerer I, Skazikis G, Geier M, Szuecs M, Glatzer M, Schymalla M, Adebahr S, Verhoeff J, Siva S, Roeder F, Kahl K, Blanck O, Kaul D, Fritz C, Schaule J, Guckenberger M. Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database. Radiat Oncol 2021; 16:4.
Jan 6, 2021
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database
Jan 6, 2021

Radiat Oncol 2021; 16:4

Kroeze Stephanie G C, Eckert Franziska, Lohaus Fabian, Sackerer Irina, Skazikis Georgios, Geier Michael, Szuecs Marcella, Glatzer Markus, Schymalla Markus M, Adebahr Sonja, Verhoeff Joost J C, Siva Shankar, Roeder Falk, Kahl Klaus H, Blanck Oliver, Kaul David, Fritz Corinna, Schaule Jana, Guckenberger Matthias

more
Jan 6, 2021
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies
Weber M, Imperiali M, Salimi Y, Fleisch F, Cusini A, Heer S, Renz H, Paprotny M, Kohler P, Vernazza P, Risch L, Bodmer T, Egli K, Risch M, Thiel S, Grossmann K, Nigg S, Wohlwend N, Lung T, Hillmann D, Ritzler M, Ferrara F, Bigler S, Kahlert C. Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies. Dis Markers 2021; 2021:8810196.
Jan 6, 2021
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies
Jan 6, 2021

Dis Markers 2021; 2021:8810196

Weber Myriam C, Imperiali Mauro, Salimi Yacir, Fleisch Felix, Cusini Alexia, Heer Sonja, Renz Harald, Paprotny Matthias, Kohler Philipp, Vernazza Pietro, Risch Lorenz, Bodmer Thomas, Egli Konrad, Risch Martin, Thiel Sarah L, Grossmann Kirsten, Nigg Susanne, Wohlwend Nadia, Lung Thomas, Hillmann Dorothea, Ritzler Michael, Ferrara Francesca, Bigler Susanna, Kahlert Christian

more
Jan 6, 2021
Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway
Maul J, Dippel M, Yawalkar N, Trüeb R, Schlapbach C, Mainetti C, Lapointe A, Laffitte E, Kolios A, Jalili A, Häusermann P, Cozzio A, Conrad C, Anzengruber F, Navarini A. Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway. Dermatology 2021; 237:166-178.
Jan 6, 2021
Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway
Jan 6, 2021

Dermatology 2021; 237:166-178

Maul Julia-Tatjana, Dippel Michaela, Yawalkar Nikhil, Trüeb Ralph, Schlapbach Christoph, Mainetti Carlo, Lapointe Anne-Karine, Laffitte Emmanuel, Kolios Antonios G A, Jalili Ahmad, Häusermann Peter, Cozzio Antonio, Conrad Curdin, Anzengruber Florian, Navarini Alexander A

more
Jan 5, 2021
Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge
Allwood B, Byrne A, Meghji J, Rachow A, van der Zalm M, Schoch O. Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge. Respiration 2021; 100:751-763.
Jan 5, 2021
Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge
Jan 5, 2021

Respiration 2021; 100:751-763

Allwood Brian W, Byrne Anthony, Meghji Jamilah, Rachow Andrea, van der Zalm Marieke M, Schoch Otto

more
Jan 5, 2021
Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"
Schneeweiss A, Lux M, Müller V, Nabieva N, Overkamp F, Tesch H, Laakmann E, Taran F, Seitz J, Thomssen C, Untch M, Wimberger P, Wuerstlein R, Volz B, Wallwiener D, Wallwiener M, Klein E, Kurbacher C, Ettl J, Luftner D, Beckmann M, Belleville E, Fasching P, Fehm T, Geberth M, Häberle L, Hadji P, Hartkopf A, Hielscher C, Huober J, Ruckhäberle E, Janni W, Kolberg H, Brucker S. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany". Breast 2021; 55:138-139.
Jan 5, 2021
Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"
Jan 5, 2021

Breast 2021; 55:138-139

Schneeweiss Andreas, Lux Michael P, Müller Volkmar, Nabieva Naiba, Overkamp Friedrich, Tesch Hans, Laakmann Elena, Taran Florin-Andrei, Seitz Julia, Thomssen Christoph, Untch Michael, Wimberger Pauline, Wuerstlein Rachel, Volz Bernhard, Wallwiener Diethelm, Wallwiener Markus, Klein Evelyn, Kurbacher Christian M, Ettl Johannes, Luftner Diana, Beckmann Matthias W, Belleville Erik, Fasching Peter A, Fehm Tanja N, Geberth Matthias, Häberle Lothar, Hadji Peyman, Hartkopf Andreas D, Hielscher Carsten, Huober Jens, Ruckhäberle Eugen, Janni Wolfgang, Kolberg Hans Christian, Brucker Sara Y

more

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy